Depression and Anxiety Trial, Recruiting (NCT07333027)

Depression and Anxiety Trial, Recruiting NCT07333027 Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07333027 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been formally diagnosed with depression (either a single episode or recurring episodes) by a doctor or clinical psychologist, using a structured diagnostic interview called the M.I.N.I.
People who have been admitted to one of the two participating psychiatric clinics, either as a planned or emergency admission
People aged 18 years or older
People who have a good enough understanding of spoken and written German to participate
People who are willing and able to give their free and informed agreement to take part

Who may not be able to join:

People who are currently unable to give informed consent — for example, due to severe psychotic symptoms, a deeply withdrawn or unresponsive state, or thinking that is dominated by thoughts of suicide
People who have previously taken part in this study
People who are pregnant or breastfeeding
People whose inpatient stay turns out to be shorter than 7 days, even if all other criteria were met at the time of joining

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Franziska Sonnauer, Dr. med., M.Sc., Department of Psychiatry and Psychotherapy, Friedrich-Alexander Universität Erlangen-Nürnberg

Phone: 00499131-8534597

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07333027

Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 00499131-8534597

More information: https://clinicaltrials.gov/study/NCT07333027

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been formally diagnosed with depression (either a single episode or recurring episodes) by a doctor or clinical psychologist, using a structured diagnostic interview called the M.I.N.I.
People who have been admitted to one of the two participating psychiatric clinics, either as a planned or emergency admission
People aged 18 years or older
People who have a good enough understanding of spoken and written German to participate
People who are willing and able to give their free and informed agreement to take part

Who may not be able to join:

People who are currently unable to give informed consent — for example, due to severe psychotic symptoms, a deeply withdrawn or unresponsive state, or thinking that is dominated by thoughts of suicide
People who have previously taken part in this study
People who are pregnant or breastfeeding
People whose inpatient stay turns out to be shorter than 7 days, even if all other criteria were met at the time of joining

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Friedrich-Alexander-Universität Erlangen-Nürnberg

Registry

ClinicalTrials.gov

Start date

5 February 2026

Est. completion

1 September 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Depression (symptom severity); Loneliness; Depression; Loneliness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov